Pawel Muranski

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Dendritic Cells

Prostate Cancer

Immune Response

Respiratory Syndrome Coronavirus

Top Venues

bioRxiv : the preprint server for biology

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Mithil Soni, Edoardo Migliori, Jianing Fu, Amer Assal, Hei Ton Chan, Jian Pan, Prabesh Khatiwada, Rodica Ciubotariu, Michael S May, Marcus Pereira, Valeria De Giorgi, Megan Sykes, Markus Y Mapara, Pawel Muranski
The prospect of universal coronavirus immunity: a characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses. bioRxiv : the preprint server for biology (2023)
Mithil Soni, Edoardo Migliori, Jianing Fu, Amer Assal, Hei Ton Chan, Jian Pan, Prabesh Khatiwada, Rodica Ciubotariu, Michael S May, Marcus Pereira, Valeria De Giorgi, Megan Sykes, Markus Y Mapara, Pawel Muranski
The prospect of universal coronavirus immunity: a characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses. bioRxiv : the preprint server for biology (2023)
Mithil Soni, Edoardo Migliori, Jianing Fu, Amer Assal, Hei Ton Chan, Jian Pan, Prabesh Khatiwada, Rodica Ciubotariu, Michael S May, Marcus Pereira, Valeria De Giorgi, Megan Sykes, Markus Y Mapara, Pawel Muranski
The prospect of universal coronavirus immunity: a characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses. bioRxiv : the preprint server for biology (2023)
Zoila A Lopez-Bujanda, Aleksandar Z Obradovic, Thomas R Nirschl, Laura Crowley, Rodney Macedo, Alexandros Papachristodoulou, Timothy O'Donnell, Uri Laserson, Jelani C Zarif, Ran Reshef, Tiezheng Yuan, Mithil K Soni, Emmanuel S Antonarakis, Michael C Haffner, H Benjamin Larman, Michael M Shen, Pawel Muranski, Charles G Drake
TGM4: an immunogenic prostate-restricted antigen. Journal for immunotherapy of cancer 9 (6) (2022)